Developmental expression of alpha 1-antichymotrypsin in brain may be related to astrogliosis.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Neurobiology of Aging

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1837594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebral amyloid angiopathy and astrocytic gliosis in Alzheimer's disease

  2004cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Distribution of the protease inhibitor alpha 1-antichymotrypsin in cerebral and systemic amyloid.

  1990cited by this paper
• General and dramatic glial reaction in Alzheimer brains

  1990cited by this paper
• Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

  1990cited by this paper
• The protease inhibitory properties of the Alzheimer's beta-amyloid precursor protein.

  1990cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• Astrocytes and the plaques of Alzheimer's disease

  1990cited by this paper
• Alpha 1-antichymotrypsin is present together with the beta-protein in monkey brain amyloid deposits.

  1989cited by this paper
• Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor.

  1989cited by this paper
• Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain

  1989cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper
• Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.

  1989cited by this paper
• The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II

  1989cited by this paper
• A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

  1988cited by this paper
• Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

  1988cited by this paper
• Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

  1988cited by this paper
• Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

  1988cited by this paper
• Sulfated glycosaminoglycans in Alzheimer's disease.

  1987cited by this paper
• The molecular pathogenesis of astrogliosis in scrapie and Alzheimer's disease.

  1987cited by this paper
• Aluminosilicates and senile plaque formation in Alzheimer's disease.

  1986cited by this paper
• Neuropathological Classification of Huntington's Disease

  1985cited by this paper
• Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene.

  1985cited by this paper
• Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

  1985cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Sequence of a cDNA clone encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments.

  1984cited by this paper
• Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

  1984cited by this paper

• Increased Concentration of Anti-Egg Albumin Antibodies in Cerebrospinal Fluid and Serum of Patients with Alzheimer’s Disease—Discussion on Human Serpins’ Similarity and Probable Involvement in the Disease Mechanism

  2025influential citation
• Astrocyte-derived SerpinA3N promotes neuroinflammation and epileptic seizures by activating the NF-κB signaling pathway in mice with temporal lobe epilepsy

  2023cites this paper
• Serpin Signatures in Prion and Alzheimer’s Diseases

  2022cites this paper
• Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis

  2022cites this paper
• Discovery and verification of multiple sclerosis candidate biomarkers using iTRAQ and SID-SRM

  2017cites this paper
• Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation

  2016cites this paper
• Identification and quantification of host proteins in the vesicular fluid of porcine Taenia solium cysticerci.

  2014cites this paper
• Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.

  2013cites this paper
• The association of ACT -17 A/T polymorphism with Alzheimer's disease: a meta-analysis.

  2013cites this paper
• Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.

  2005cites this paper
• Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models

  2005influential citation
• Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition

  2004cites this paper
• Ultrastructural localization of Alzheimer amyloid β/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes

  2004cites this paper
• Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment

  2003cites this paper
• Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer's disease.

  2002cites this paper
• Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

  2001cites this paper
• Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease

  2001cites this paper
• Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer's disease.

  2001cites this paper
• The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.

  2001cites this paper
• Alpha 1-antichymotrypsin inhibits A beta degradation in vitro and in vivo.

  2000cites this paper
• Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.

  2000cites this paper
• Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1

  2000cites this paper
• Vascular Endothelium

  1998cites this paper
• The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer's disease.

  1998cites this paper
• Pigment epithelium‐derived factor (PEDF) has direct effects on the metabolism and proliferation of microglia and indirect effects on astrocytes

  1997cites this paper
• Synthesis and secretion of active alpha 1-antichymotrypsin by murine primary astrocytes.

  1996cites this paper
• Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides.

  1996cites this paper
• The cerebral expression of plasma protein genes in different species.

  1995cites this paper
• Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1.

  1995cites this paper
• Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA

  1995cites this paper
• Expression of complement C1qB and C4 mRNAs during rat brain development.

  1994cites this paper
• Cellular and molecular biology of Alzheimer's disease and animal models.

  1994cites this paper
• Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.

  1994cites this paper
• Inflammatory mechanisms in Alzheimer's disease: implications for therapy.

  1994cites this paper
• Identification of a Chymotrypsin‐Like Mast Cell Protease in Rat Brain Capable of Generating the N‐Terminus of the Alzheimer Amyloid β‐Protein

  1993cites this paper
• Differential expression of alpha 1-antichymotrypsin in the aged human brain.

  1993cites this paper
• Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes.

  1993cites this paper
• Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro.

  1993cites this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

  1993cites this paper
• The role of the acute-phase protein alpha 1-antichymotrypsin in brain dysfunction and injury.

  1992cites this paper
• The Involvement of Proteases, Protease Inhibitors, and an Acute Phase Response in Alzheimer's Disease a

  1992cites this paper
• Purification and cloning of brain proteases capable of degrading the beta-amyloid precursor protein.

  1992cites this paper
• Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning.

  1992cites this paper
• The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease.

  1992cites this paper
• Aged Non‐Human Primates: An Animal Model of Age‐Associated Neurodegenerative Disease

  1991cites this paper